| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/30/2008 | CN101167711A Chloromycetin eyedrops and preparation method thereof |
| 04/30/2008 | CN101167710A Chloromycetin eyedrops with long quality guaranteed period and preparation method thereof |
| 04/30/2008 | CN101167709A Compound methylephedrine capsule and preparation method thereof |
| 04/30/2008 | CN101167708A New use of 6,7-dehydroroyleanone in pharmaceutical |
| 04/30/2008 | CN101167707A New use of protocatechuic aldehyde |
| 04/30/2008 | CN101167703A Chloromycetin soft capsule and preparation method thereof |
| 04/30/2008 | CN101167702A Roxoithromycin osmotic pump tablet and preparation method thereof |
| 04/30/2008 | CN101167701A Tamsulosin hydrochloride double-layer osmotic pump controlled-releasing tablet and preparation method thereof |
| 04/30/2008 | CN101167700A Nifedipine controlled-releasing tablet and preparation method thereof |
| 04/30/2008 | CN101167698A Freezing-dried preparation containing pirarubicin |
| 04/30/2008 | CN101167697A Donepezils compound long-acting slow-releasing and controlled-releasing composition and preparation method thereof |
| 04/30/2008 | CN101167695A Composition with improved light stability |
| 04/30/2008 | CN101167578A Tablet food and preparation process thereof |
| 04/30/2008 | CN101167575A Tea polysaccharide lozenge |
| 04/30/2008 | CN101167493A Dairy product containing rich coenzyme Q10 and preparation method thereof |
| 04/30/2008 | CN100384981C Red rice mould mutant strain and its use in preparing fermented product with blood pressure reducing activity |
| 04/30/2008 | CN100384884C Method for separating and purify dermatansulfate and low-molecular heparan sulfate from sodium heparan product |
| 04/30/2008 | CN100384882C Method for producing low viscosity algin |
| 04/30/2008 | CN100384878C Antibodies specific for human cd22 and their therapeutic anddiagnostic uses |
| 04/30/2008 | CN100384875C 蛋白质 Protein |
| 04/30/2008 | CN100384868C Oestrogen derivatives as inhibitors of steroid sulphatase. |
| 04/30/2008 | CN100384867C Novel solid body forms of mesoprogestin 11-beta-[4E-(hydroxyimino methyl)-phenyl]-17-alpha-methoxy methyl-17 beta-methoxy-estra-4,9-dien-3-one |
| 04/30/2008 | CN100384866C Process for prepn. of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for epoxidation of olifinic double bonds |
| 04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 04/30/2008 | CN100384859C Nucleotide analogs |
| 04/30/2008 | CN100384857C Cephalosporin ester compound resisting beta-lactamase and its salt |
| 04/30/2008 | CN100384856C Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 04/30/2008 | CN100384852C Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase |
| 04/30/2008 | CN100384851C Epothilone derivatives |
| 04/30/2008 | CN100384850C Galantamine derivative and its preparation process and use |
| 04/30/2008 | CN100384849C Quinoline 3-amino chroman derivatives |
| 04/30/2008 | CN100384847C Adenosine a2a receptor antagonists |
| 04/30/2008 | CN100384845C Process for formulation of antibiotic compounds |
| 04/30/2008 | CN100384844C Xanthine phosphodiesterase V inhibitor polymorphs |
| 04/30/2008 | CN100384843C CGRP receptor antagonists |
| 04/30/2008 | CN100384841C Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 04/30/2008 | CN100384839C Preparation process of [(substituted pyridyl) methyl] sulfenyl-1H-benzimidazole compound and its antimer zinc salt |
| 04/30/2008 | CN100384838C Novel benzylpiperidine compound |
| 04/30/2008 | CN100384837C Novel farnesyl protein transferase inhibitors as antitumor |
| 04/30/2008 | CN100384836C Novel cyclic amide derivatives |
| 04/30/2008 | CN100384834C Epothilone derivatives |
| 04/30/2008 | CN100384833C Therapeutic chroman compounds |
| 04/30/2008 | CN100384830C Derivative of cyclo membranousol kind and application thereof |
| 04/30/2008 | CN100384827C Ophthalmic compositions for treating ocular hypertension |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/30/2008 | CN100384824C Acetyl 2-hydroxy-1, 3-diaminoalkanes |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/30/2008 | CN100384822C 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 04/30/2008 | CN100384821C Cetp activity inhibitors |
| 04/30/2008 | CN100384820C Phosphate prodrugs of fluorooxindoles |
| 04/30/2008 | CN100384819C Peptide inhibitors of SMAC protein binding to inhibitor of apoptosis proteins (IAP) |
| 04/30/2008 | CN100384813C Process for preparing nateglinide and intermediates thereof |
| 04/30/2008 | CN100384489C Hemostatic devices and methods of making same |
| 04/30/2008 | CN100384482C Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 04/30/2008 | CN100384480C Delivery system for nucleic acids |
| 04/30/2008 | CN100384479C Method for preparing bile acid adsorbent of beta cyclo dextrin polymer |
| 04/30/2008 | CN100384477C Complex of modafinil and cyclodextrin |
| 04/30/2008 | CN100384474C Skin immune function controlling agents |
| 04/30/2008 | CN100384472C Antigen-specific lgE antibody production inhibitors |
| 04/30/2008 | CN100384454C Use of composition in preparing medicine for for preventing and treating cornea malacia |
| 04/30/2008 | CN100384452C Use of composition in preparing medicine and food dual purpose nutritive product for preventing and treating computer vision syndrome |
| 04/30/2008 | CN100384449C Use of composition in preparing medicine for preventing and treating vision syndrome due to television and computer display screen light injury |
| 04/30/2008 | CN100384447C Medicine for treating gynecopathy and its preparing method |
| 04/30/2008 | CN100384446C Medicine emplastrum for treating osteoproliferation and its preparing method |
| 04/30/2008 | CN100384441C Pharmaceutical composition for treating acute kidney failure |
| 04/30/2008 | CN100384435C Saline solution for treating nasal cavity disease and its application device |
| 04/30/2008 | CN100384434C Gel containing betulaprenol from ginkgo leaves and its preparing method |
| 04/30/2008 | CN100384433C Remedies |
| 04/30/2008 | CN100384432C Application of Chinese medicine polysaccharide as colonic drug-transferring carrier |
| 04/30/2008 | CN100384431C Traditional Chinese medicine compositions |
| 04/30/2008 | CN100384430C Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 04/30/2008 | CN100384429C Capsule for treating cardiac and cerebral vascular diseases and its preparing method and application |
| 04/30/2008 | CN100384428C Oral disintegrating tablet of notoginseng triterpenes and preparation method thereof |
| 04/30/2008 | CN100384427C Injection preparation containing active component adefuwei or its salt and its preparation method |
| 04/30/2008 | CN100384426C Solid dispersion containing active component adefuwei or its salt and its preparation method |
| 04/30/2008 | CN100384425C Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 04/30/2008 | CN100384424C Synergistic methods and compositions for treating cancer |
| 04/30/2008 | CN100384423C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/30/2008 | CN100384422C Anti-microbial composition comprising a metal ion chelating agent |
| 04/30/2008 | CN100384421C N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 04/30/2008 | CN100384420C Use of substituted pyrazoles in preparing medicine compositions for treating allergies |
| 04/30/2008 | CN100384419C Epothilone slow-release implanting composition and use |
| 04/30/2008 | CN100384418C Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
| 04/30/2008 | CN100384417C Pyranoindazoles and their use for the treatment of glaucoma |
| 04/30/2008 | CN100384416C Medicinal composition for treating cerebrovascular disease |
| 04/30/2008 | CN100384415C Preparation method of magnetic nanometer granule containing mitocin-C |
| 04/30/2008 | CN100384414C Medicine containing ketone effective component |
| 04/30/2008 | CN100384413C Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 04/30/2008 | CN100384412C Methods and compositions for inhibiting 5 'alpha'-reductase activity |
| 04/30/2008 | CN100384411C Oral carbidopa/levodopa disintegrant tablet |
| 04/30/2008 | CN100384410C Parenteral dosage forms comprising suspension of tramadol salt and diclofenac salt |
| 04/30/2008 | CN100384409C Use of triethylene-tetramine as antitumour auxiliary drug |
| 04/30/2008 | CN100384408C Novel composition |
| 04/30/2008 | CN100384406C Coating method for microcapsule of lysine hydrochloride |
| 04/29/2008 | USRE40278 Heterocyclic amines having central nervous system activity |
| 04/29/2008 | US7365231 2,2-bis(4-(4-amino-3-hydroxyphenoxy)phenyl)adamantane; arrest and differentiation in human colon cancer cells; less toxic; reacting an aromatic diol with at least one 5-halo-2-nitrophenol in the presence of at least one inorganic base in an organic solvent; |
| 04/29/2008 | US7365225 Aryl dicarboxamides |
| 04/29/2008 | US7365224 In polymorphic Form A free of other polymorphic forms, used as an antiallergen to treat, e.g., bronchial asthma; high solubility and bioavailability |
| 04/29/2008 | US7365223 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 04/29/2008 | US7365221 Viricides; aids therapy |